TembexaActive Ingredient(s): Brincidofovir
FDA Approved: * June 4, 2021
Pharm Company: * CHIMERIX
Brincidofovir, sold under the brand name Tembexa, is an antiviral drug used to treat smallpox. Brincidofovir is a prodrug of cidofovir. Conjugated to a lipid, the compound is designed to release cidofovir intracellularly, allowing for higher intracellular and lower plasma concentrations of cidofovir, effectively increasing its activity against dsDNA viruses, as well as oral bioavailability. The most common side effects include diarrhea, nausea, vomiting, ... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.